Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

2.07
Delayed Data
As of Sep 29
 +0.01 / +0.49%
Today’s Change
0.94
Today|||52-Week Range
2.90
+100.97%
Year-to-Date

Today’s Trading

Previous close2.06
Today’s open2.10
Day’s range2.03 - 2.15
Volume628,524
Average volume (3 months)457,986
Market cap$175.1M
Dividend yield--
Data as of 3:59pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)+35.48%
Earnings growth (this year)-2.50%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+636.17%
P/E ratioNM
Price/Sales7.14
Price/Book8.74

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...+0.27+2.81%
ACRXAcelRx Pharmaceutica...-0.18-4.62%
OCULOcular Therapeutix I...-0.12-1.74%
PRQRProQR Therapeutics N...-0.55-7.53%
Data as of 4:00pm ET, 09/29/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$11.9M
Annual profit (last year)-$16.4M
Net profit margin-137.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Gil van Bokkelen
President, Chief Operating Officer &
Secretary
William B. J. Lehmann
Corporate headquarters
Cleveland, Ohio

Forecasts

Search for Jobs